ProShares UltraShort Health Care
3 hedge funds and large institutions have $628K invested in ProShares UltraShort Health Care in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 4 closing their positions.
11% more call options, than puts
Call options by funds: $120M | Put options by funds: $108M
8.77% less ownership
Funds ownership: 40.76% → 31.99% (-8.8%)
36% less capital inflows, than outflows
Capital inflows: $295K | Capital outflows: $458K
40% less funds holding
Funds holding: 5 → 3 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$291K |
| 2 |
JP Morgan Chase
New York
|
+$3.75K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Old Mission Capital
Chicago,
Illinois
|
-$188K |
| 2 |
G
GenTrust
Miami,
Florida
|
-$141K |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$116K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$11K |
| 5 |
PH
Pinnacle Holdings
Tulsa,
Oklahoma
|
-$1.38K |
RXD Hedge Fund Activity: Q3 2022 in Review
3 of the 5,831 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q3 2022, worth a combined $628K — down 14% from $733K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RXD and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $291K. The largest seller was Old Mission Capital, exiting entirely with an estimated $188K sold.
- 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q3 2022, down from 5 in Q2 2022.
- Funds reported $628K of ProShares UltraShort Health Care stock for Q3 2022, down 14% quarter-over-quarter.
- 2 funds opened new ProShares UltraShort Health Care positions in Q3 2022 and 4 closed out, a net change of -2 holders.
- The largest ProShares UltraShort Health Care buyer in Q3 2022 was Citadel Advisors, an estimated $291K added.
- The largest ProShares UltraShort Health Care seller in Q3 2022 was Old Mission Capital, an estimated $188K sold.
Based on aggregated 13F filings for Q3 2022.